Provided by Tiger Trade Technology Pte. Ltd.

Chemours

16.77
-1.2200-6.78%
Post-market: 16.66-0.1100-0.66%19:53 EST
Volume:3.98M
Turnover:66.69M
Market Cap:2.51B
PE:-6.53
High:17.06
Open:17.01
Low:16.27
Close:17.99
52wk High:21.85
52wk Low:9.13
Shares:149.89M
Float Shares:141.48M
Volume Ratio:1.19
T/O Rate:2.82%
Dividend:0.35
Dividend Rate:2.09%
EPS(TTM):-2.5700
EPS(LYR):-2.5700
ROE:-93.80%
ROA:2.49%
PB:10.05
PE(LYR):-6.53

Loading ...

Chemours: in Q4, Anticipates Consolidated Net Sales to Decrease 10-15% Sequentially Given Seasonal Impacts

THOMSON REUTERS
·
Nov 07, 2025

Chemours: in Q4, Also Anticipates Capital Expenditures to Be in the Range of $50 Million

THOMSON REUTERS
·
Nov 07, 2025

Chemours Approves New Executive Severance Policy with Enhanced Payouts

Reuters
·
Nov 01, 2025

OKX will list CC (Canton Network) Perpetual Swap trading pair pre-market.

Blockbeats
·
Oct 31, 2025

Binance to Launch CC Unsettled Perpetual Futures Pre-market Trading

Blockbeats
·
Oct 31, 2025

Press Release: Facephi Reports Solid 1H25 Results, Expects Strong Acceleration in 2H25, and Provides 2025--2026 Financial Guidance

Dow Jones
·
Oct 31, 2025

Chemours Cuts Quarterly Dividend to $0.0875 a Share From $0.25, Payable Dec. 15 to Shareholders of Record on Nov. 14

MT Newswires Live
·
Oct 30, 2025

The Chemours Company announces $0.0875 per share quarterly dividend

Reuters
·
Oct 30, 2025

The Chemours Company to Release Third Quarter 2025 Financial Results

Reuters
·
Oct 17, 2025

Chemours price target lowered to $18 from $19 at Mizuho

TIPRANKS
·
Oct 16, 2025

Chemours - Extends $1.05 Bln Term Loan Maturity to 2032 - SEC Filing

THOMSON REUTERS
·
Oct 16, 2025

Chemours - to Sell Receivables up to EUR180 Mln to BNP - SEC Filing

THOMSON REUTERS
·
Oct 16, 2025

RBC Raises Price Target on Chemours to $19 From $15, Keeps Outperform Rating

MT Newswires Live
·
Oct 14, 2025

U.S. RESEARCH ROUNDUP-Applovin, Caterpillar, ESAB

Reuters
·
Oct 14, 2025

Investment Company Luminus Loaded Up on This Leading Industrials Stock. Is It a Buy?

Motley Fool
·
Oct 12, 2025

Luminus Trims Its Hefty Chemours Position

Motley Fool
·
Oct 07, 2025

Chemours Is Maintained at Buy by UBS

Dow Jones
·
Oct 07, 2025

UBS Adjusts Price Target on Chemours to $21 From $17, Maintains Buy Rating

MT Newswires Live
·
Oct 06, 2025

Chemours price target raised to $21 from $17 at UBS

TIPRANKS
·
Oct 06, 2025

Chemours Co : UBS Raises Target Price to $21 From $17

THOMSON REUTERS
·
Oct 06, 2025